home > pmps > winter 2020 > striving to ship environmentally friendly
Pharmaceutical Manufacturing and Packing Sourcer

Striving to Ship Environmentally Friendly

The challenges that we, as human beings, face today in protecting the environment are changing the way we think and act, both in private life and in business. As global warming continues at a rapid pace, researchers and scientists from a wide range of disciplines believe that adapting to climate change is the greatest challenge of the 21st century in economic, social, and environmental terms (1).

The industrial sector plays a major role in the emission of CO2. Therefore, all factors related to the product lifecycle and the transportation of goods are at the heart of a worldwide movement. Thus, it is inevitable to implement innovative strategies to reduce CO2 emissions and develop new forms of management towards more corporate social responsibility.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

About the author

Aat van der Meer was born in 1962 in Rotterdam, the Netherlands. As the son of a transport entrepreneur, he was infected with the logistics virus at a young age. After 26 years of experience in transport and logistics, Aat joined Dachser, one of the world’s leading third-party logistics providers, in 2006 and established a new Dachser branch in the Netherlands. In 2007, he became Managing Director of Dachser in the Netherlands and, two years later, also in Belgium. In 2013 and 2014, Luxembourg and the air and sea freight activities in the Benelux were added to his responsibilities.
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the £11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners — Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI — will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>

White Papers

High Containment FIBCs Offer a Safe and Cost Effective Alternative to their Rigid Counterparts

ILC Dover

As the need for powder containment and manufacturing in accordance with cGMP standards has grown over the years, companies have sought new alternatives to rigid IBCs. Recently high containment Flexible Intermediate Bulk Containers (FIBCs) have emerged which offer an alternative that provides both powder containment and the benefits of shipping with flexibles.
More info >>

Industry Events

Clinical Trial Supply Europe

11-12 March 2020, Madrid, Spain

The 21st annual edition promises to grow on the success of 2019’s excellent conference which saw delegates from Europe’s largest pharmaceutical companies and biotech innovators come together to discuss, debate and unpack the latest trends in clinical supply chain innovation. 2020 will offer delegates the opportunity to address the growing need for agility within the supply chain in response to increasingly complex trial demands. With a stream dedicated to supply operations and another to innovative uses of technology in the supply chain, delegates will get the chance to gain practical take-aways that they can apply to their own studies.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement